insights_auto
Why is ORX down 5,32%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
1,32 SEK
arrow_downward
-5,32%(-0,074) 1D
6-ноя., 16:43:03 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,47 SEK
High
1,47 SEK
Low
1,31 SEK
Mkt. cap
46,23 млн
Avg. vol.
320,60 миң
Volume
463,69 миң
P/E ratio
0,06
52-wk high
36,00 SEK
52-wk low
1,30 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,47 SEK
High
1,47 SEK
Low
1,31 SEK
Mkt. cap
46,23 млн
Avg. vol.
320,60 миң
Volume
463,69 миң
P/E ratio
0,06
52-wk high
36,00 SEK
52-wk low
1,30 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
FF News
·
45 мүнөт мурун
Gregg Jaclin on What Happens After the SEC Agrees to Take a Second Look
CNBC
·
30 мүнөт мурун
Opening Bell: November 6, 2026
The Motley Fool
·
22 мүнөт мурун
Nasdaq Stock Market Correction: Here's the Most Attractive Bargain in the "Magnificent Seven"
CNN
·
5 саат мурун
What sparked the stock market’s $2.5 trillion sell-off?
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com